United States· US:50419-750_9b14492a-5ae2-4d0a-85c0-212636daf8cd
LAMPIT
A nifurtimox product containing nifurtimox, registered in United States by Bayer HealthCare Pharmaceuticals Inc.. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Nifurtimox is registered in 4 of 19 countries.
Countries holding a registration under ATC P01CC01 (nifurtimox), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Nifurtimox · ATC P01CC01
4 / 19 countries
- Germany
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NIFURTIMOX
- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- P01CC01
- ATC class
- Nifurtimox
- Defined daily dose
- 0.7 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1150419750011 BOTTLE in 1 CARTON (50419-750-01) / 100 TABLET, FILM COATED in 1 BOTTLE
- ndc1150419-750-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
7 interactions on record for nifurtimox.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nifurtimox · interactions on record
7 records
- 4 severe
- 3 moderate
Most severe, free to view
- EthanolB05XX04severe
- EthanolV03AB16severe
- EthanolV03AZ01severe
- EthanolV07AB03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nifurtimox in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainLAMPIT 120 MG COMPRIMIDOSBayer Hispania S.L.
- GermanyLampitBayer Vital Gmbh
- United KingdomNifurtimox 120mg tabletsSpecial Order
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Lampit
- Spain · Lampit
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/846a8cbb-ccac-4027-827d-a5aa62c56aa2 GET /v1/drugs/846a8cbb-ccac-4027-827d-a5aa62c56aa2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "30",
"substance": "NIFURTIMOX",
"productndc": "50419-750",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA213464",
"marketing_category": "NDA"
}See everything about nifurtimox.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.